McDermott Will & Schulte

临床试验

计划入组 200 人 · 首次发布于 2024 年 1 月 23 日

已完成

NCT01245647

Will Having Alcohol Treatment Improve Functioning?

计划入组 19 人 · 首次发布于 2010 年 11 月 22 日

已完成

NCT01554904

Study Will Test the Theory That Training With the Facial-Flex Exercise Device Will Improve Snoring in Patients

计划入组 18 人 · 首次发布于 2012 年 3 月 15 日

药物

查看全部 79 →

Small Molecule

Experimental

Inosine(Rejuvesol)

C₁₀H₁₂N₄O₅

Biotech

Approved

Dill

Small Molecule

Approved

Piperaquine(Eurartesim)

相关疾病：Malaria caused by Plasmodium falciparum

C₂₉H₃₂Cl₂N₆ · Rx

机构

查看全部 61 →

MCDERMOTT LABORATORIES LIMITED

Ireland

The University Of Texas Health Science Center At San Antonio

United States

Julian Chun, Andreas Wolf Fach, Bernd Nowak, Johannes Renczes, Boris Schmidt, Detlef Scherer, Britta Schulte-Hahn, Thomas Voigtländer und Axel Schmermund

Germany

资讯

查看全部 21002 →

4个月前

Certara Divests Regulatory and Medical Writing Business to Veristat for $135 Million to Focus on AI-Driven Drug Development

上个月

WindRose Health Investors Recapitalizes Verified Clinical Trials, Appoints Howard Miller as CEO to Accelerate Growth

9个月前

临床试验

Post Polypectomy Bleeding. Que Sera, Sera? Whatever Will be, Will be?

Will Having Alcohol Treatment Improve Functioning?

Study Will Test the Theory That Training With the Facial-Flex Exercise Device Will Improve Snoring in Patients

药物

Inosine(Rejuvesol)

Dill

Piperaquine(Eurartesim)

机构

MCDERMOTT LABORATORIES LIMITED

The University Of Texas Health Science Center At San Antonio

Julian Chun, Andreas Wolf Fach, Bernd Nowak, Johannes Renczes, Boris Schmidt, Detlef Scherer, Britta Schulte-Hahn, Thomas Voigtländer und Axel Schmermund

资讯

Certara Divests Regulatory and Medical Writing Business to Veristat for $135 Million to Focus on AI-Driven Drug Development

WindRose Health Investors Recapitalizes Verified Clinical Trials, Appoints Howard Miller as CEO to Accelerate Growth

Sobi Acquires Arthrosi Therapeutics for $950M to Advance Next-Generation Gout Treatment